Barclays PLC Dia Medica Therapeutics Inc. Transaction History

Barclays PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$3.43 - $4.65 $15,832 - $21,464	-4,616 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$3.1 - $4.32 $9,944 - $13,858	3,208 Added 227.84%	4,616 $19,000
Q2 2021 Aug 13, 2021	SELL	$4.45 - $9.91 $8,917 - $19,859	-2,004 Reduced 58.73%	1,408 $6,000
Q1 2021 May 13, 2021	BUY	$7.76 - $10.43 $26,477 - $35,587	3,412 New	3,412 $31,000

4.22M

8.2K

200

Ticker DMAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,443,100
Market Cap $138M
Description
DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.